MedTech firms grow more comfortable with FDA's Quality Management System Regulation amid inspection concerns

At The MedTech Conference in Boston, a senior industry executive reported that the medtech sector is gradually accepting the new Quality Management System Regulation (QMSR) despite early worries.

The QMSR, introduced by the FDA, aims to strengthen oversight of medical device manufacturers. Companies initially expressed anxiety about meeting the new inspection requirements, but recent feedback suggests the transition is proceeding more smoothly.

Experts said the industry's growing confidence could reduce inspection‑related disruptions and help align product quality with regulatory expectations, signaling a positive shift in the medtech landscape.